Theratechnologies Announces Publication of TH1902 Preclinical Data in Peer-Reviewed Journal, Cancer Science
MONTREAL, Aug. 13, 2021 (GLOBE NEWSWIRE) — Theratechnologies, Inc. (Theratechnologies, or Company) (TSX: TH) (NASDAQ:…
MONTREAL, Aug. 13, 2021 (GLOBE NEWSWIRE) — Theratechnologies, Inc. (Theratechnologies, or Company) (TSX: TH) (NASDAQ:…
Combination of Synergistic Organizations Results in Broad CDMO Service with Capabilities Spanning from Pre-IND Development…
Reported positive, statistically significant top-line efficacy and safety data from pivotal Phase 3 NORSE TWO…
– Enrolled the First Patient in the Phase 2/3 Pivotal Trial of AL102 for the…
TRG-100 is now being evaluated in broad range of bladder disorders RAANANA, Israel, Aug. 13,…
Continued enrollment in Phase 1/2 trial of first-in-class p53 Y220C reactivator PC14586 CRANBURY, N.J., Aug….
Consolidated Net Revenue of $21.7 Million up 117% vs. Second Quarter of 2020 Consolidated Net…
TORONTO, Aug. 13, 2021 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:…
SAN CARLOS, Calif., Aug. 13, 2021 (GLOBE NEWSWIRE) — BioCardia®, Inc. (Nasdaq: BCDA), a developer of…
AUSTIN, Texas, Aug. 13, 2021 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a…
Nominees bring depth and diversity of scientific, commercial and financial experience to Board NEW YORK…
Multiple peer-reviewed journal publications and presentations at scientific forums drive value and recognition across the…
MIRAMAR, Fla., Aug. 13, 2021 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company”) (NASDAQ: HCWB),…
Strengthened the Company’s balance sheet by completing the business combination with Therapeutics Acquisition Corp (“RACA”),…
Conference Call to be Held Today at 8:30 A.M. ET HOUSTON, Aug. 13, 2021 (GLOBE…
–-Type A meeting with FDA expected late Q3 to define pathway to potential approval for…
— Phase 1/2 ABILITY Study of MDNA11 in patients with advanced solid tumors remains on…
SOUTH SAN FRANCISCO, Calif., Aug. 13, 2021 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic biotechnology…
First quarter revenue up 23% over prior yearStrong cash balance of $770 millionContinuing to advance…
Longeveron to hold conference call today at 8:00 AM EDT MIAMI, Aug. 13, 2021 (GLOBE…